Lifecycle Partnership

Partners for life

Aegis has a full understanding of the product lifecycle, from basic research through product maturation. We establish strategic partnerships with our clients and help them design purposeful tactics for communicating with Key Opinion Leaders (KOLs), investigators, physicians, and other Health Care Professionals (HCPs). These tactics are effective because they are strategically aligned with lifecycle plans and are designed to build an understanding of:

  • Scientific platforms and the rationale for scientific and clinical studies
  • Clinical study design, including measurement tools and endpoints
  • The latest theories on disease pathogenesis
  • Existing and emerging therapies and the science behind them
  • Factors in treatment decisions and risk/benefit considerations
  • Patient identification, monitoring, and management
  • Product information

To find out how Aegis can assist you in any stage, contact , VP Sales and Marketing.

Where are you in the lifecyle?
Research

Problem

In research the executive team needs to understand the molecular basis of the disease and the rationale for funding a particular molecule’s early stage development.

Solution

Aegis can help identify and explain the molecular basis of the disease and the theoretical rationale for the drug’s effectiveness.

Audience

Internal executives and external KOLs

Development

Problem

We need KOLs who contribute to the ongoing understanding of the disease and therapy during clinical trials and who can help achieve rapid trial enrollment to determine study outcomes.

Solution

Aegis can help establish the scientific platform and clinical rationale for a novel therapeutic.

Audience

KOL/Investigators and Physicians

Solutions

Expert meetings
E-learning
Slide kits
Clinical trial training tools

Pre-Launch

Problem

The marketplace is crowded; this drug’s efficacy story needs to be told in simple compelling terms. We need to educate our internal personnel about the molecular disease pathogenesis, the disease state, the MOA of our new therapeutic and current standards of care.

Solution

Develop educational programs across all functions that prepare company personnel for drug launch.

Audience

Internal departments: Medical Affairs, Marketing, Sales
Externals: Investigators, clinicians

Solutions

Advisory Boards
E-learning
Slide kits
Backgrounders
Sales oriented tools

Launch

Problem

HCPs have a knowledge gap in using the therapy and managing patients.

Solution

Explain use of drug for patient treatment and management of the disease - The Story for Patient Care and Management.

Audience

Health Care Professionals (HCPs) and Managed Care Professionals

Solutions

Advisory Boards
E-learning
Slide kits
Formulary Kits

Post Launch

Problem

Maintaining and growing enthusiasm for the therapeutic in an increasingly competitive environment.

Solution

Continued education on clinical relevance and benefit.

Audience

Health Care Professionals (HCPs) and patients

Solutions

E-learning
Slide kits